Bliss GVS Pharma Ltd.
•₹ 579.1-0.18%
2026-08-21
PROS
- Company is almost debt free
- Latest quarter profit grew 83.5% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.40x)
- Company generates healthy free cash flow
- Company has a consistent dividend-paying track record
CONS
- A large part of profit comes from other income (43.8% of PBT)
- Company has a low return on equity of 7.0% over last 3 years
- Company has a low return on capital employed of 9.8%
- Operating margins have contracted to 15.4% from 23.6%
- Company has delivered a poor profit growth of 7.5% over past five years
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | BLISSGVS | 572.70 | 44.69 | 6086.38 | 0.26 | 51.37 | 15.80 | 285.58 | 37.65 | 17.40 | 26.75 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109 | 171 | 161 | 164 | 149 | 183 | 180 | 156 | 163 | 190 | 165 | 212 | 222 | |
| 98 | 129 | 133 | 139 | 122 | 159 | 154 | 142 | 131 | 172 | 138 | 167 | 179 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 7 | 11 | 8 | 8 | 7 | 10 | 12 | 9 | 11 | 26 | 10 | 9 | 9 |
| Interest | 1 | 1 | 2 | 2 | 1 | 3 | 1 | 1 | 5 | 3 | 1 | 2 | 0 |
| Depreciation | 5 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 8 | 9 |
| 11 | 46 | 29 | -15 | 26 | 24 | 30 | 14 | 31 | 33 | 25 | 44 | 51 | |
| Tax % | 31.26% | 26.44% | 27.35% | 24.75% | 25.74% | 28.67% | 29.29% | 20.26% | 31.12% | 25.88% | 26.41% | 26.57% | 24.59% |
| Net Profit | 8 | 34 | 21 | -11 | 19 | 17 | 21 | 11 | 21 | 25 | 19 | 32 | 39 |
| 1 | 3 | 2 | -1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 0 | |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 109
- 98
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 5
- 11
- Tax %
- 31.26%
- Net Profit
- 8
- 1
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 171
- 129
- Operating Profit
- —
- OPM %
- —
- Other Income
- 11
- Interest
- 1
- Depreciation
- 6
- 46
- Tax %
- 26.44%
- Net Profit
- 34
- 3
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 161
- 133
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 2
- Depreciation
- 6
- 29
- Tax %
- 27.35%
- Net Profit
- 21
- 2
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 164
- 139
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 2
- Depreciation
- 6
- -15
- Tax %
- 24.75%
- Net Profit
- -11
- -1
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 149
- 122
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 6
- 26
- Tax %
- 25.74%
- Net Profit
- 19
- 2
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 183
- 159
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 3
- Depreciation
- 6
- 24
- Tax %
- 28.67%
- Net Profit
- 17
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 180
- 154
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 1
- Depreciation
- 7
- 30
- Tax %
- 29.29%
- Net Profit
- 21
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 156
- 142
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 1
- Depreciation
- 7
- 14
- Tax %
- 20.26%
- Net Profit
- 11
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 163
- 131
- Operating Profit
- —
- OPM %
- —
- Other Income
- 11
- Interest
- 5
- Depreciation
- 8
- 31
- Tax %
- 31.12%
- Net Profit
- 21
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 190
- 172
- Operating Profit
- —
- OPM %
- —
- Other Income
- 26
- Interest
- 3
- Depreciation
- 8
- 33
- Tax %
- 25.88%
- Net Profit
- 25
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 165
- 138
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 1
- Depreciation
- 8
- 25
- Tax %
- 26.41%
- Net Profit
- 19
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 212
- 167
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 2
- Depreciation
- 8
- 44
- Tax %
- 26.57%
- Net Profit
- 32
- 3
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 222
- 179
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 0
- Depreciation
- 9
- 51
- Tax %
- 24.59%
- Net Profit
- 39
- 0
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 348 | 298 | 427 | 442 | 466 | 636 | 598 | 605 | 667 | 730 | 788 | |
| 247 | 209 | 333 | 342 | 374 | 527 | 508 | 498 | 576 | 611 | 657 | |
| Operating Profit | 110 | 99 | 129 | 137 | 111 | 142 | 141 | 141 | 128 | 178 | — |
| OPM % | 31 | 33 | 30 | 31 | 24 | 22 | 24 | 23 | 19 | 24 | — |
| Other Income | 9 | 11 | 36 | 37 | 19 | 33 | 51 | 34 | 36 | 59 | 54 |
| Interest | 9 | 7 | 3 | 7 | 6 | 4 | 10 | 6 | 7 | 11 | 6 |
| Depreciation | 6 | 6 | 6 | 9 | 14 | 14 | 15 | 24 | 27 | 31 | 32 |
| 95 | 87 | 120 | 122 | 91 | 126 | 116 | 70 | 94 | 133 | 154 | |
| Tax % | 38 | 34 | 38 | 24 | 26 | 27 | 26 | 28 | 27 | 27 | 26 |
| Net Profit | 59 | 57 | 74 | 92 | 68 | 93 | 85 | 51 | 69 | 97 | 114 |
| EPS | 0 | 0 | 0 | 0 | 6 | 9 | 8 | 5 | 7 | 9 | — |
| Dividend Payout % | 10 | 18 | 14 | 6 | 8 | 6 | 6 | 10 | 8 | 16 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 6 | 6 | 7 | 9 | 7 | 9 | 8 | 5 | 7 | 9 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 6 | 6 | 7 | 9 | 7 | 9 | 8 | 5 | 7 | 9 | — |
Mar 2017
- 348
- 247
- Operating Profit
- 110
- OPM %
- 31
- Other Income
- 9
- Interest
- 9
- Depreciation
- 6
- 95
- Tax %
- 38
- Net Profit
- 59
- EPS
- 0
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2018
- 298
- 209
- Operating Profit
- 99
- OPM %
- 33
- Other Income
- 11
- Interest
- 7
- Depreciation
- 6
- 87
- Tax %
- 34
- Net Profit
- 57
- EPS
- 0
- Dividend Payout %
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2019
- 427
- 333
- Operating Profit
- 129
- OPM %
- 30
- Other Income
- 36
- Interest
- 3
- Depreciation
- 6
- 120
- Tax %
- 38
- Net Profit
- 74
- EPS
- 0
- Dividend Payout %
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2020
- 442
- 342
- Operating Profit
- 137
- OPM %
- 31
- Other Income
- 37
- Interest
- 7
- Depreciation
- 9
- 122
- Tax %
- 24
- Net Profit
- 92
- EPS
- 0
- Dividend Payout %
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2021
- 466
- 374
- Operating Profit
- 111
- OPM %
- 24
- Other Income
- 19
- Interest
- 6
- Depreciation
- 14
- 91
- Tax %
- 26
- Net Profit
- 68
- EPS
- 6
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2022
- 636
- 527
- Operating Profit
- 142
- OPM %
- 22
- Other Income
- 33
- Interest
- 4
- Depreciation
- 14
- 126
- Tax %
- 27
- Net Profit
- 93
- EPS
- 9
- Dividend Payout %
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2023
- 598
- 508
- Operating Profit
- 141
- OPM %
- 24
- Other Income
- 51
- Interest
- 10
- Depreciation
- 15
- 116
- Tax %
- 26
- Net Profit
- 85
- EPS
- 8
- Dividend Payout %
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2024
- 605
- 498
- Operating Profit
- 141
- OPM %
- 23
- Other Income
- 34
- Interest
- 6
- Depreciation
- 24
- 70
- Tax %
- 28
- Net Profit
- 51
- EPS
- 5
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2025
- 667
- 576
- Operating Profit
- 128
- OPM %
- 19
- Other Income
- 36
- Interest
- 7
- Depreciation
- 27
- 94
- Tax %
- 27
- Net Profit
- 69
- EPS
- 7
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2026
- 730
- 611
- Operating Profit
- 178
- OPM %
- 24
- Other Income
- 59
- Interest
- 11
- Depreciation
- 31
- 133
- Tax %
- 27
- Net Profit
- 97
- EPS
- 9
- Dividend Payout %
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
TTM
- 788
- 657
- Operating Profit
- —
- OPM %
- —
- Other Income
- 54
- Interest
- 6
- Depreciation
- 32
- 154
- Tax %
- 26
- Net Profit
- 114
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 8%
- 5 Years:
- 9%
- 3 Years:
- 7%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 4%
- 5 Years:
- 7%
- 3 Years:
- 4%
STOCK PRICE CAGR
- 10 Years:
- 16%
- 5 Years:
- 40%
- 3 Years:
- 85%
- 1 Year:
- 249%
RETURN ON EQUITY
- 10 Years:
- 10%
- 5 Years:
- 8%
- 3 Years:
- 7%
- Last Year:
- 9%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 |
| 481 | 531 | 593 | 673 | 735 | 831 | 918 | 970 | 1,042 | 1,133 | |
| 61 | 88 | 41 | 36 | 56 | 41 | 36 | 11 | 3 | 0 | |
| Trade Payables | 64 | 35 | 31 | 56 | 67 | 84 | 76 | 54 | 60 | 96 |
| 49 | 29 | 61 | 80 | 77 | 113 | 99 | 100 | 95 | 89 | |
| Total Liabilities | 666 | 694 | 736 | 855 | 946 | 1,080 | 1,140 | 1,146 | 1,211 | 1,329 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 75 | 72 | 78 | 179 | 174 | 224 | 325 | 330 | 368 | 420 | |
| Capital Work in Progress | 2 | 0 | 43 | 0 | 2 | 22 | 3 | 8 | 21 | 4 |
| 22 | 19 | 19 | 19 | 18 | 18 | 18 | 19 | 19 | 19 | |
| 28 | 40 | 55 | 61 | 84 | 90 | 74 | 89 | 82 | 111 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 400 | 429 | 457 | |
| Cash & Bank | 84 | 70 | 93 | 87 | 120 | 149 | 85 | 169 | 171 | 111 |
| 456 | 492 | 447 | 510 | 548 | 576 | 635 | 131 | 122 | 208 | |
| Total Assets | 666 | 694 | 736 | 855 | 946 | 1,080 | 1,140 | 1,146 | 1,211 | 1,329 |
| Total Debt | 75 | 94 | 72 | 88 | 89 | 86 | 77 | 66 | 51 | 0 |
| Net Working Capital | 403 | 439 | 486 | 517 | 531 | 599 | 576 | 657 | 641 | 658 |
| Contingent Liabilities | 44 | 3 | 12 | 14 | 30 | 22 | 10 | 56 | 5 | 11 |
| Book Value per Share | 47.66 | 52.49 | 58.49 | 66.21 | 72.31 | 81.16 | 89.11 | 93.68 | 99.87 | 108.10 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 75 | 94 | 72 | 88 | 89 | 86 | 77 | 66 | 51 | 0 |
| Net Working Capital | 403 | 439 | 486 | 517 | 531 | 599 | 576 | 657 | 641 | 658 |
| Contingent Liabilities | 44 | 3 | 12 | 14 | 30 | 22 | 10 | 56 | 5 | 11 |
| Book Value per Share | 47.66 | 52.49 | 58.49 | 66.21 | 72.31 | 81.16 | 89.11 | 93.68 | 99.87 | 108.10 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2017
- Equity Capital
- 10
- 481
- 61
- Trade Payables
- 64
- 49
- Total Liabilities
- 666
- 75
- Capital Work in Progress
- 2
- 22
- 28
- 0
- Cash & Bank
- 84
- 456
- Total Assets
- 666
- Total Debt
- 75
- Net Working Capital
- 403
- Contingent Liabilities
- 44
- Book Value per Share
- 47.66
- Face Value
- 1.00
- Total Debt
- 75
- Net Working Capital
- 403
- Contingent Liabilities
- 44
- Book Value per Share
- 47.66
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 10
- 531
- 88
- Trade Payables
- 35
- 29
- Total Liabilities
- 694
- 72
- Capital Work in Progress
- 0
- 19
- 40
- 0
- Cash & Bank
- 70
- 492
- Total Assets
- 694
- Total Debt
- 94
- Net Working Capital
- 439
- Contingent Liabilities
- 3
- Book Value per Share
- 52.49
- Face Value
- 1.00
- Total Debt
- 94
- Net Working Capital
- 439
- Contingent Liabilities
- 3
- Book Value per Share
- 52.49
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 10
- 593
- 41
- Trade Payables
- 31
- 61
- Total Liabilities
- 736
- 78
- Capital Work in Progress
- 43
- 19
- 55
- 0
- Cash & Bank
- 93
- 447
- Total Assets
- 736
- Total Debt
- 72
- Net Working Capital
- 486
- Contingent Liabilities
- 12
- Book Value per Share
- 58.49
- Face Value
- 1.00
- Total Debt
- 72
- Net Working Capital
- 486
- Contingent Liabilities
- 12
- Book Value per Share
- 58.49
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 10
- 673
- 36
- Trade Payables
- 56
- 80
- Total Liabilities
- 855
- 179
- Capital Work in Progress
- 0
- 19
- 61
- 0
- Cash & Bank
- 87
- 510
- Total Assets
- 855
- Total Debt
- 88
- Net Working Capital
- 517
- Contingent Liabilities
- 14
- Book Value per Share
- 66.21
- Face Value
- 1.00
- Total Debt
- 88
- Net Working Capital
- 517
- Contingent Liabilities
- 14
- Book Value per Share
- 66.21
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 10
- 735
- 56
- Trade Payables
- 67
- 77
- Total Liabilities
- 946
- 174
- Capital Work in Progress
- 2
- 18
- 84
- 0
- Cash & Bank
- 120
- 548
- Total Assets
- 946
- Total Debt
- 89
- Net Working Capital
- 531
- Contingent Liabilities
- 30
- Book Value per Share
- 72.31
- Face Value
- 1.00
- Total Debt
- 89
- Net Working Capital
- 531
- Contingent Liabilities
- 30
- Book Value per Share
- 72.31
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 10
- 831
- 41
- Trade Payables
- 84
- 113
- Total Liabilities
- 1,080
- 224
- Capital Work in Progress
- 22
- 18
- 90
- 0
- Cash & Bank
- 149
- 576
- Total Assets
- 1,080
- Total Debt
- 86
- Net Working Capital
- 599
- Contingent Liabilities
- 22
- Book Value per Share
- 81.16
- Face Value
- 1.00
- Total Debt
- 86
- Net Working Capital
- 599
- Contingent Liabilities
- 22
- Book Value per Share
- 81.16
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 10
- 918
- 36
- Trade Payables
- 76
- 99
- Total Liabilities
- 1,140
- 325
- Capital Work in Progress
- 3
- 18
- 74
- 0
- Cash & Bank
- 85
- 635
- Total Assets
- 1,140
- Total Debt
- 77
- Net Working Capital
- 576
- Contingent Liabilities
- 10
- Book Value per Share
- 89.11
- Face Value
- 1.00
- Total Debt
- 77
- Net Working Capital
- 576
- Contingent Liabilities
- 10
- Book Value per Share
- 89.11
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 10
- 970
- 11
- Trade Payables
- 54
- 100
- Total Liabilities
- 1,146
- 330
- Capital Work in Progress
- 8
- 19
- 89
- 400
- Cash & Bank
- 169
- 131
- Total Assets
- 1,146
- Total Debt
- 66
- Net Working Capital
- 657
- Contingent Liabilities
- 56
- Book Value per Share
- 93.68
- Face Value
- 1.00
- Total Debt
- 66
- Net Working Capital
- 657
- Contingent Liabilities
- 56
- Book Value per Share
- 93.68
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 11
- 1,042
- 3
- Trade Payables
- 60
- 95
- Total Liabilities
- 1,211
- 368
- Capital Work in Progress
- 21
- 19
- 82
- 429
- Cash & Bank
- 171
- 122
- Total Assets
- 1,211
- Total Debt
- 51
- Net Working Capital
- 641
- Contingent Liabilities
- 5
- Book Value per Share
- 99.87
- Face Value
- 1.00
- Total Debt
- 51
- Net Working Capital
- 641
- Contingent Liabilities
- 5
- Book Value per Share
- 99.87
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 11
- 1,133
- 0
- Trade Payables
- 96
- 89
- Total Liabilities
- 1,329
- 420
- Capital Work in Progress
- 4
- 19
- 111
- 457
- Cash & Bank
- 111
- 208
- Total Assets
- 1,329
- Total Debt
- 0
- Net Working Capital
- 658
- Contingent Liabilities
- 11
- Book Value per Share
- 108.10
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 658
- Contingent Liabilities
- 11
- Book Value per Share
- 108.10
- Face Value
- 1.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 38 | 23 | 48 | 63 | 67 | 114 | 44 | 82 | 97 | 123 | |
| Cash from Investing | -29 | 16 | -68 | -60 | -62 | -92 | -13 | -66 | -78 | -51 |
| Cash from Financing | -15 | -22 | 9 | -6 | -12 | -13 | -26 | -21 | -27 | -75 |
| -6 | 17 | -11 | -3 | -6 | 9 | 5 | -4 | -7 | -4 | |
| Free Cash Flow | 38 | 22 | -4 | -3 | 56 | 36 | -52 | 49 | 20 | 63 |
| OCF / Net Profit | 0.65 | 0.40 | 0.65 | 0.68 | 0.99 | 1.23 | 0.51 | 1.62 | 1.41 | 1.27 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 109 | 106 | 32 | 85 | 108 | 115 |
| OCF / Net Profit | 0.65 | 0.40 | 0.65 | 0.68 | 0.99 | 1.23 | 0.51 | 1.62 | 1.41 | 1.27 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 109 | 106 | 32 | 85 | 108 | 115 |
Mar 2017
- 38
- Cash from Investing
- -29
- Cash from Financing
- -15
- -6
- Free Cash Flow
- 38
- OCF / Net Profit
- 0.65
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.65
- Cumulative 5-Year FCF
- 0
Mar 2018
- 23
- Cash from Investing
- 16
- Cash from Financing
- -22
- 17
- Free Cash Flow
- 22
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- 0
Mar 2019
- 48
- Cash from Investing
- -68
- Cash from Financing
- 9
- -11
- Free Cash Flow
- -4
- OCF / Net Profit
- 0.65
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.65
- Cumulative 5-Year FCF
- 0
Mar 2020
- 63
- Cash from Investing
- -60
- Cash from Financing
- -6
- -3
- Free Cash Flow
- -3
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 0
Mar 2021
- 67
- Cash from Investing
- -62
- Cash from Financing
- -12
- -6
- Free Cash Flow
- 56
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- 109
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- 109
Mar 2022
- 114
- Cash from Investing
- -92
- Cash from Financing
- -13
- 9
- Free Cash Flow
- 36
- OCF / Net Profit
- 1.23
- Cumulative 5-Year FCF
- 106
- OCF / Net Profit
- 1.23
- Cumulative 5-Year FCF
- 106
Mar 2023
- 44
- Cash from Investing
- -13
- Cash from Financing
- -26
- 5
- Free Cash Flow
- -52
- OCF / Net Profit
- 0.51
- Cumulative 5-Year FCF
- 32
- OCF / Net Profit
- 0.51
- Cumulative 5-Year FCF
- 32
Mar 2024
- 82
- Cash from Investing
- -66
- Cash from Financing
- -21
- -4
- Free Cash Flow
- 49
- OCF / Net Profit
- 1.62
- Cumulative 5-Year FCF
- 85
- OCF / Net Profit
- 1.62
- Cumulative 5-Year FCF
- 85
Mar 2025
- 97
- Cash from Investing
- -78
- Cash from Financing
- -27
- -7
- Free Cash Flow
- 20
- OCF / Net Profit
- 1.41
- Cumulative 5-Year FCF
- 108
- OCF / Net Profit
- 1.41
- Cumulative 5-Year FCF
- 108
Mar 2026
- 123
- Cash from Investing
- -51
- Cash from Financing
- -75
- -4
- Free Cash Flow
- 63
- OCF / Net Profit
- 1.27
- Cumulative 5-Year FCF
- 115
- OCF / Net Profit
- 1.27
- Cumulative 5-Year FCF
- 115
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 5.73 | 5.53 | 7.22 | 8.95 | 6.54 | 8.94 | 8.21 | 4.84 | 6.55 | 9.16 |
| Book Value (₹) | 47.66 | 52.49 | 58.49 | 66.21 | 72.31 | 81.16 | 89.11 | 93.68 | 99.87 | 108.10 |
| Dividend per Share (₹) | 0.60 | 1.00 | 1.00 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 1.50 |
| Cash EPS (₹) | 6.28 | 6.08 | 7.77 | 9.81 | 7.88 | 10.27 | 9.66 | 7.08 | 9.11 | 12.09 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 31.29% | 33.34% | 30.22% | 31.04% | 23.82% | 22.29% | 23.55% | 17.70% | 13.08% | 15.43% |
| Net Margin % | 16.88% | 19.11% | 17.45% | 20.89% | 14.50% | 14.56% | 14.29% | 8.36% | 9.85% | 12.54% |
| ROE % | 12.80% | 11.04% | 13.00% | 14.36% | 9.45% | 11.68% | 9.66% | 5.31% | 6.78% | 8.82% |
| ROCE % | 19.25% | 15.60% | 18.80% | 17.75% | 12.02% | 14.68% | 12.89% | 7.36% | 9.31% | 12.77% |
| 8.67% | 8.38% | 10.41% | 11.61% | 7.50% | 9.15% | 7.70% | 4.43% | 5.85% | 7.63% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 255 | 319 | 267 | 308 | 295 | 217 | 246 | 241 | 216 | 209 |
| Inventory Days | 26 | 42 | 40 | 48 | 57 | 50 | 50 | 49 | 45 | 46 |
| Payable Days | 108 | 124 | 54 | 67 | 88 | 80 | 93 | 79 | 61 | 83 |
| 173 | 237 | 254 | 289 | 264 | 187 | 204 | 211 | 200 | 171 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.15x | 0.17x | 0.12x | 0.13x | 0.12x | 0.10x | 0.08x | 0.07x | 0.05x | 0.00x |
| Interest Coverage (x) | 11.46x | 13.49x | 39.08x | 19.38x | 16.40x | 30.23x | 12.50x | 13.10x | 15.30x | 13.01x |
| 3.65x | 4.21x | 6.28x | 5.12x | 4.63x | 4.11x | 4.76x | 6.72x | 6.13x | 4.90x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 6.63% | -14.40% | 43.20% | 3.60% | 5.33% | 36.70% | -5.97% | 1.19% | 10.20% | 9.38% |
| Operating Profit Growth % | -8.35% | -9.26% | 29.61% | 6.40% | -19.17% | 27.92% | -0.64% | -0.18% | -9.15% | 39.08% |
| Net Profit Growth % | -9.88% | -3.58% | 30.55% | 24.05% | -26.90% | 37.28% | -7.75% | -40.75% | 36.18% | 40.46% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -41.06% | 35.30% | 39.90% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 23.29x | 17.96x | 23.54x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.20x | 1.18x | 1.99x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.44% | 0.43% | 0.70% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 7.65x | 8.75x | 12.21x |
Mar 2017
- EPS (₹)
- 5.73
- Book Value (₹)
- 47.66
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 6.28
- Operating Margin %
- 31.29%
- Net Margin %
- 16.88%
- ROE %
- 12.80%
- ROCE %
- 19.25%
- 8.67%
- Debtor Days
- 255
- Inventory Days
- 26
- Payable Days
- 108
- 173
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 11.46x
- 3.65x
- Revenue Growth %
- 6.63%
- Operating Profit Growth %
- -8.35%
- Net Profit Growth %
- -9.88%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 5.53
- Book Value (₹)
- 52.49
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 6.08
- Operating Margin %
- 33.34%
- Net Margin %
- 19.11%
- ROE %
- 11.04%
- ROCE %
- 15.60%
- 8.38%
- Debtor Days
- 319
- Inventory Days
- 42
- Payable Days
- 124
- 237
- Debt to Equity (x)
- 0.17x
- Interest Coverage (x)
- 13.49x
- 4.21x
- Revenue Growth %
- -14.40%
- Operating Profit Growth %
- -9.26%
- Net Profit Growth %
- -3.58%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 7.22
- Book Value (₹)
- 58.49
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 7.77
- Operating Margin %
- 30.22%
- Net Margin %
- 17.45%
- ROE %
- 13.00%
- ROCE %
- 18.80%
- 10.41%
- Debtor Days
- 267
- Inventory Days
- 40
- Payable Days
- 54
- 254
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 39.08x
- 6.28x
- Revenue Growth %
- 43.20%
- Operating Profit Growth %
- 29.61%
- Net Profit Growth %
- 30.55%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 8.95
- Book Value (₹)
- 66.21
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 9.81
- Operating Margin %
- 31.04%
- Net Margin %
- 20.89%
- ROE %
- 14.36%
- ROCE %
- 17.75%
- 11.61%
- Debtor Days
- 308
- Inventory Days
- 48
- Payable Days
- 67
- 289
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 19.38x
- 5.12x
- Revenue Growth %
- 3.60%
- Operating Profit Growth %
- 6.40%
- Net Profit Growth %
- 24.05%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 6.54
- Book Value (₹)
- 72.31
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 7.88
- Operating Margin %
- 23.82%
- Net Margin %
- 14.50%
- ROE %
- 9.45%
- ROCE %
- 12.02%
- 7.50%
- Debtor Days
- 295
- Inventory Days
- 57
- Payable Days
- 88
- 264
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 16.40x
- 4.63x
- Revenue Growth %
- 5.33%
- Operating Profit Growth %
- -19.17%
- Net Profit Growth %
- -26.90%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 8.94
- Book Value (₹)
- 81.16
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 10.27
- Operating Margin %
- 22.29%
- Net Margin %
- 14.56%
- ROE %
- 11.68%
- ROCE %
- 14.68%
- 9.15%
- Debtor Days
- 217
- Inventory Days
- 50
- Payable Days
- 80
- 187
- Debt to Equity (x)
- 0.10x
- Interest Coverage (x)
- 30.23x
- 4.11x
- Revenue Growth %
- 36.70%
- Operating Profit Growth %
- 27.92%
- Net Profit Growth %
- 37.28%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 8.21
- Book Value (₹)
- 89.11
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 9.66
- Operating Margin %
- 23.55%
- Net Margin %
- 14.29%
- ROE %
- 9.66%
- ROCE %
- 12.89%
- 7.70%
- Debtor Days
- 246
- Inventory Days
- 50
- Payable Days
- 93
- 204
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- 12.50x
- 4.76x
- Revenue Growth %
- -5.97%
- Operating Profit Growth %
- -0.64%
- Net Profit Growth %
- -7.75%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 4.84
- Book Value (₹)
- 93.68
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 7.08
- Operating Margin %
- 17.70%
- Net Margin %
- 8.36%
- ROE %
- 5.31%
- ROCE %
- 7.36%
- 4.43%
- Debtor Days
- 241
- Inventory Days
- 49
- Payable Days
- 79
- 211
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 13.10x
- 6.72x
- Revenue Growth %
- 1.19%
- Operating Profit Growth %
- -0.18%
- Net Profit Growth %
- -40.75%
- -41.06%
- P/E (x)
- 23.29x
- P/B (x)
- 1.20x
- Dividend Yield %
- 0.44%
- 7.65x
Mar 2025
- EPS (₹)
- 6.55
- Book Value (₹)
- 99.87
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 9.11
- Operating Margin %
- 13.08%
- Net Margin %
- 9.85%
- ROE %
- 6.78%
- ROCE %
- 9.31%
- 5.85%
- Debtor Days
- 216
- Inventory Days
- 45
- Payable Days
- 61
- 200
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 15.30x
- 6.13x
- Revenue Growth %
- 10.20%
- Operating Profit Growth %
- -9.15%
- Net Profit Growth %
- 36.18%
- 35.30%
- P/E (x)
- 17.96x
- P/B (x)
- 1.18x
- Dividend Yield %
- 0.43%
- 8.75x
Mar 2026
- EPS (₹)
- 9.16
- Book Value (₹)
- 108.10
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 12.09
- Operating Margin %
- 15.43%
- Net Margin %
- 12.54%
- ROE %
- 8.82%
- ROCE %
- 12.77%
- 7.63%
- Debtor Days
- 209
- Inventory Days
- 46
- Payable Days
- 83
- 171
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 13.01x
- 4.90x
- Revenue Growth %
- 9.38%
- Operating Profit Growth %
- 39.08%
- Net Profit Growth %
- 40.46%
- 39.90%
- P/E (x)
- 23.54x
- P/B (x)
- 1.99x
- Dividend Yield %
- 0.70%
- 12.21x
Documents
Announcements
- Shareholders meeting
2026-08-20 - Bliss GVS Pharma Limited has informed the Exchange regarding Notice of Postal Ballot
- Copy of Newspaper Publication
2026-08-14 - Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding the extract of the statement of un-audited standalone andconsolidated financial results for the quarter ended June 30, 2026.
Annual Reports
Credit Ratings
Nothing filed yet.